Medical Disclaimer
This article is for informational purposes only and does not constitute medical advice. The information provided should not be used for diagnosing or treating a health condition. Always consult your healthcare provider before starting, stopping, or changing any medication or treatment plan. Individual results may vary.
Last reviewed: January 17, 2025
GLP-1 Medication Comparison: Making the Right Choice
Part 5 of the GLP-1 Starter Kit | 15 min read
Medical Disclaimer
This comparison is for educational purposes only. Medication decisions should always be made in consultation with your healthcare provider based on your specific medical history and needs.
You're standing in your doctor's office, prescription pad in hand, and facing a choice: Ozempic, Mounjaro, Wegovy, or Zepbound? Or maybe you're already on one medication and wondering if you should switch.
The GLP-1 medication landscape has exploded in recent years, creating both exciting options and confusing decisions. Each medication has different FDA approvals, dosing schedules, efficacy data, side effect profiles, and costs.
💡Key Takeaways
- Tirzepatide (Mounjaro/Zepbound) shows 18-22% average weight loss vs semaglutide's (Ozempic/Wegovy) 15-17%
- Ozempic and Wegovy are the same drug (semaglutide) at different doses - same with Mounjaro and Zepbound (tirzepatide)
- Insurance coverage depends on diagnosis: 70-80% cover diabetes meds, only 30-40% cover weight loss meds
- Brand-name costs $900-$1,400/month without insurance; compounded versions cost $200-$500/month with quality risks
Quick Reference: At-a-Glance Comparison
Ozempic
Semaglutide for Diabetes | 10-15% weight loss | $900-$1,000/mo
Wegovy
Semaglutide for Weight Loss | 15-17% weight loss | $1,300-$1,400/mo
Mounjaro
Tirzepatide for Diabetes | 15-22% weight loss | $1,000-$1,100/mo
Zepbound
Tirzepatide for Weight Loss | 18-22% weight loss | $1,000-$1,100/mo
Rybelsus
Oral Semaglutide | 8-12% weight loss | $900-$1,000/mo
Compounded
Generic Versions | Unknown efficacy | $200-$400/mo
Understanding the Two Drug Classes
Before comparing specific medications, you need to understand the fundamental difference between the two main types of GLP-1 drugs.
Class 1: GLP-1 Agonists (Semaglutide)
Medications: Ozempic, Wegovy, Rybelsus
Mechanism: Activates GLP-1 receptors only
Half-life: ~7 days (weekly injection)
Manufacturer: Novo Nordisk
Class 2: Dual GIP/GLP-1 Agonists (Tirzepatide)
Medications: Mounjaro, Zepbound
Mechanism: Activates both GLP-1 and GIP receptors
Half-life: ~5 days (weekly injection)
Manufacturer: Eli Lilly
Why Dual Action Matters
Tirzepatide (Mounjaro, Zepbound) activates both GLP-1 and GIP receptors, creating a synergistic effect.
18-22%
Tirzepatide average weight loss
15-17%
Semaglutide average weight loss
50% vs 33%
More people achieve >20% weight loss
Individual Responses Vary
Some people respond better to semaglutide, others to tirzepatide. There's no way to predict which will work better for you without trying. Both are highly effective medications.
FDA Approvals: Why They Matter for Insurance
The FDA approves medications for specific indications. This matters enormously for insurance coverage.
Type 2 Diabetes Approvals
- Ozempic (semaglutide)
- Mounjaro (tirzepatide)
- Rybelsus (oral semaglutide)
Insurance: 70-80% of plans cover
Weight Management Approvals
- Wegovy (semaglutide)
- Zepbound (tirzepatide)
Insurance: Only 30-40% of plans cover
The Insurance Loophole
Same drug, different approval
Ozempic and Wegovy are identical medications (semaglutide) at different doses. Mounjaro and Zepbound are also identical (tirzepatide). Doctors frequently prescribe the diabetes version "off-label" for weight loss because it's more likely to be covered by insurance.
Off-label use is:
- Legal and common in medical practice
- Medically appropriate if your doctor prescribes it
- May affect insurance coverage
- Still the same medication with identical effects
Semaglutide Medications: Detailed Analysis
Ozempic (Semaglutide for Type 2 Diabetes)
Quick Facts
FDA Approval: December 2017 for type 2 diabetes
Delivery: Weekly subcutaneous injection
Dosing: 0.25mg → 0.5mg → 1mg → 2mg (max)
Average Weight Loss: 10-15% over 68 weeks
Who it's for:
- Adults with type 2 diabetes
- Often prescribed off-label for weight loss (better insurance coverage)
- People who want proven efficacy with extensive safety data
Dosing Schedule
Clinical Trial Results (SUSTAIN trials):
10-15%
Average weight loss over 68 weeks
1.5-2.0%
A1C reduction in diabetics
26%
Reduction in cardiovascular events
Example: 200 lb person loses ~20-30 lbs over 16 months
Pros:
- ✅ Excellent insurance coverage for diabetics
- ✅ Lower maximum dose may mean fewer side effects
- ✅ Extensive safety data (approved since 2017)
- ✅ Proven cardiovascular benefits
- ✅ Multi-dose pen (one pen lasts 4 weeks)
Cons:
- ❌ Lower average weight loss than Wegovy or Mounjaro
- ❌ Off-label use for weight loss only (insurance may deny)
- ❌ Maximum dose lower than Wegovy (2mg vs 2.4mg)
Monthly Cost
$900-$1,000 without insurance
With insurance (diabetes): Often $25-$50 copay
Manufacturer savings card: Up to $150 off/month
Wegovy (Semaglutide for Weight Loss)
Quick Facts
FDA Approval: June 2021 for chronic weight management
Delivery: Weekly subcutaneous injection
Dosing: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg (max)
Average Weight Loss: 15-17% over 68 weeks
Who it's for:
- Adults with BMI ≥30 (obesity)
- Adults with BMI ≥27 with weight-related conditions
- People without diabetes who want maximum semaglutide dose
Dosing Schedule
Clinical Trial Results (STEP trials):
15-17%
Average weight loss over 68 weeks
48-52%
Achieve >15% weight loss
32-35%
Achieve >20% weight loss
Example: 200 lb person loses ~30-34 lbs over 16 months
Pros:
- ✅ Highest semaglutide dose available (2.4mg)
- ✅ FDA-approved specifically for weight loss
- ✅ Highest average weight loss in semaglutide class
- ✅ Single-dose pens (easier to use)
- ✅ Proven long-term weight maintenance
Cons:
- ❌ Very expensive without insurance ($1,300-$1,400/month)
- ❌ Poor insurance coverage (weight loss often excluded)
- ❌ Higher side effect rates than lower-dose Ozempic
- ❌ Frequent shortages (2021-2024)
Monthly Cost
$1,300-$1,400 without insurance
With insurance: Highly variable; many insurers exclude weight loss
Manufacturer savings card: Up to $500 off/month for 13 months
Rybelsus (Oral Semaglutide)
Quick Facts
FDA Approval: September 2019 for type 2 diabetes
Delivery: Daily oral tablet (no injections!)
Dosing: 3mg → 7mg → 14mg (max) daily
Average Weight Loss: 8-12% (lower than injections)
Who it's for:
- Adults with type 2 diabetes who want to avoid injections
- People with needle phobia
- Those who prefer daily dosing over weekly injections
Strict Dosing Requirements
Must take on empty stomach first thing in the morning
- Swallow whole with ≤4 oz water (not coffee, juice, etc.)
- Wait 30 minutes before eating, drinking, or taking other medications
- This 30-minute window is critical for absorption
Pros:
- ✅ No injections (oral tablet)
- ✅ Good for needle-phobic individuals
- ✅ Lower side effect rates than injections
- ✅ No refrigeration required
- ✅ Insurance coverage similar to Ozempic
Cons:
- ❌ Significantly lower weight loss than injections
- ❌ Strict dosing requirements (30-minute fasting window)
- ❌ Daily dosing (less convenient than weekly)
- ❌ Drug interactions possible
Monthly Cost
$900-$1,000 without insurance
With insurance: Often similar copay to Ozempic ($25-$50)
Tirzepatide Medications: Detailed Analysis
Mounjaro (Tirzepatide for Type 2 Diabetes)
Quick Facts
FDA Approval: May 2022 for type 2 diabetes
Delivery: Weekly subcutaneous injection
Dosing: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg (max)
Average Weight Loss: 15-22% over 72 weeks (dose-dependent)
Who it's for:
- Adults with type 2 diabetes
- Often prescribed off-label for weight loss
- People seeking maximum efficacy in diabetes and weight management
Dosing Schedule (6-month titration)
Clinical Trial Results (SURPASS trials):
15-22%
Average weight loss over 72 weeks
2.0-2.4%
A1C reduction (superior to all)
40-50%
Achieve >20% weight loss
Dose-Dependent Results:
- 5mg dose: ~15-17% weight loss
- 10mg dose: ~20-22% weight loss
- 15mg dose: ~21-23% weight loss
Example: 200 lb person loses ~30-44 lbs over 18 months
Pros:
- ✅ Highest average weight loss of any GLP-1 medication
- ✅ Superior A1C reduction for diabetics
- ✅ Excellent insurance coverage (diabetes indication)
- ✅ Dual mechanism (GLP-1 + GIP)
- ✅ More people achieve >20% weight loss
Cons:
- ❌ More dose increases required (6 titrations vs 4 for semaglutide)
- ❌ Longer titration period (6 months to max dose)
- ❌ Shorter room temperature storage (21 days vs 56 for Ozempic)
- ❌ Less long-term safety data than semaglutide (newer medication)
Monthly Cost
$1,000-$1,100 without insurance
With insurance (diabetes): Often $25-$50 copay
Manufacturer savings card: Up to $150 off/month
Zepbound (Tirzepatide for Weight Loss)
Quick Facts
FDA Approval: November 2023 for chronic weight management
Delivery: Weekly subcutaneous injection
Dosing: Identical to Mounjaro (2.5mg → 15mg)
Average Weight Loss: 18-22% over 72 weeks
Who it's for:
- Adults with BMI ≥30 (obesity)
- Adults with BMI ≥27 with weight-related conditions
- People without diabetes who want maximum weight loss potential
Clinical Trial Results (SURMOUNT trials):
18-22%
Average weight loss over 72 weeks
55-60%
Achieve >15% weight loss
45-52%
Achieve >20% weight loss
27-32%
Achieve >25% weight loss (unprecedented!)
Example: 200 lb person loses ~36-44 lbs over 18 months
Pros:
- ✅ Highest average weight loss of any FDA-approved obesity medication
- ✅ FDA-approved specifically for weight loss
- ✅ Nearly 50% achieve >20% weight loss
- ✅ Dual mechanism provides superior efficacy
- ✅ Same drug as Mounjaro (extensive clinical data)
- ✅ Generous manufacturer savings program
Cons:
- ❌ Most expensive out-of-pocket ($1,000-$1,100/month)
- ❌ Poor insurance coverage (weight loss exclusions common)
- ❌ Long titration period (6 months to max dose)
- ❌ Higher nausea rates than semaglutide
- ❌ Very new (approved Nov 2023—limited real-world data)
Monthly Cost
$1,000-$1,100 without insurance
With insurance: Highly variable; often excluded
Manufacturer savings card: Up to $550 off/month for 13 months (most generous!)
Compounded GLP-1 Medications: The Budget Option
FDA Warning - December 2023
The FDA issued warnings about compounded GLP-1 medications citing quality control issues, contamination risks, incorrect ingredients, and dosing errors. Compounding pharmacies aren't FDA-inspected like manufacturers.
What Are Compounded GLP-1s?
Compounded medications are custom-made by specialized pharmacies using raw pharmaceutical ingredients. During FDA-approved drug shortages, compounding pharmacies can legally produce versions of the medication.
Available compounded versions:
- Compounded semaglutide (mimics Ozempic/Wegovy)
- Compounded tirzepatide (mimics Mounjaro/Zepbound)
The Appeal: Dramatic Cost Savings
$200-$400/mo
Compounded semaglutide vs $1,300 brand-name
$300-$500/mo
Compounded tirzepatide vs $1,000 brand-name
$6,000-$13,000
Annual savings potential
The Risks: What You're Trading for Savings
Dosing Inconsistency
Brand-name: Exact dose every time (FDA-verified)
Compounded: May vary 10-30% between vials
Impact: Unpredictable results and side effects
Contamination Risk
Brand-name: Sterile, single-use pens
Compounded: Multi-dose vials (puncture risk)
Impact: Infections, abscesses, illness
Wrong Ingredients
Some use wrong salt forms (semaglutide sodium vs base)
Mislabeled concentrations
Impact: Ineffective or dangerous overdose
No Clinical Trials
Brand-name: Extensively tested
Compounded: Zero efficacy or safety studies
Impact: Unknown long-term effects
When Compounded Makes Sense
✅Consider Compounded If
❌Avoid Compounded If
Side Effect Comparison
Nausea Rates by Medication
20-30%
Rybelsus (oral) - Mildest
30-40%
Ozempic - Moderate
40-50%
Wegovy - Higher dose
35-45%
Mounjaro - Moderate
40-48%
Zepbound - Highest
Pattern
Higher doses = more nausea. Tirzepatide and semaglutide have similar rates at comparable efficacy levels. Most nausea improves after 4-8 weeks.
Which Has the "Best" Side Effect Profile?
Fewest side effects overall: Rybelsus (oral) - but lowest efficacy
Best balance: Ozempic 0.5-1mg - moderate efficacy, moderate side effects
Most tolerable high-efficacy: Mounjaro 10mg - high efficacy with manageable side effects
Highest efficacy despite side effects: Wegovy 2.4mg or Zepbound 15mg
Individual Variation
Some people have zero side effects on Zepbound 15mg. Others can't tolerate Ozempic 0.5mg. You won't know until you try. Most side effects are temporary and improve significantly after the first month.
Cost Comparison: The Financial Reality
Out-of-Pocket Costs (No Insurance)
$900-$1,000
Ozempic per month
$1,300-$1,400
Wegovy per month
$1,000-$1,100
Mounjaro per month
$1,000-$1,100
Zepbound per month
$900-$1,000
Rybelsus per month
$200-$400
Compounded per month
Reality check: Without insurance or savings programs, brand-name GLP-1s cost $12,000-$16,800 per year. This is unsustainable for most people.
Manufacturer Savings Programs
Ozempic Savings Card
Saves up to $150/month
Requires commercial insurance
Can lower cost to $25/month
Wegovy Savings Card
Saves up to $500/month for 13 months
Then up to $200/month
Most helpful for uninsured
Mounjaro Savings Card
Saves up to $150/month
Requires commercial insurance
Can lower cost to $25/month
Zepbound Savings Card
Saves up to $550/month for 13 months
Most generous program
Can reduce to ~$450-$550/month
Savings Program Restrictions
- Most require commercial insurance (employer-based)
- Cannot use with Medicare, Medicaid, or Tricare
- Many exclude if insurance covers the medication at all
- Annual limits apply
Insurance Coverage Reality
Type 2 Diabetes (Ozempic, Mounjaro, Rybelsus):
- 70-80% of commercial plans cover
- Often requires prior authorization
- Typical copay: $25-$100/month
Weight Loss (Wegovy, Zepbound):
- Only 30-40% of commercial plans cover
- Often explicitly excluded
- If covered: $50-$200+ copay
Medicare:
- Does NOT cover weight loss medications (federal law)
- Covers diabetes medications
- Average copay: $50-$150/month for diabetes
Decision Framework: Which Medication Is Right for You?
By Primary Goal
Type 2 Diabetes
Maximum A1C reduction: Mounjaro
Proven efficacy, less titration: Ozempic
No injections: Rybelsus
Weight Loss Only
Maximum weight loss (>20%): Zepbound
Proven results (15-20%): Wegovy
Budget-friendly: Ozempic off-label
Cost Priority
Lowest cost: Compounded ($200-$500/mo)
Best insurance: Ozempic/Mounjaro with savings card
Best savings program: Zepbound ($550 off/mo)
Minimize Side Effects
Lowest overall: Rybelsus (but least effective)
Best balance: Ozempic 0.5-1mg
High efficacy, tolerable: Mounjaro 10mg
Decision Tree
🎯Choose Your Medication
Your Action Plan
📋This Week: Research & Prepare
🩺At Your Doctor Appointment
✅After Getting Prescription
⚠️If Insurance Denies
The Bottom Line:
The "best" GLP-1 medication is the one that your insurance covers (or you can afford), achieves your goals, has tolerable side effects, fits your lifestyle, and you can access consistently. All GLP-1 medications are effective. The differences, while real, are less important than choosing a medication you can stick with long-term. Your journey is unique—what works for someone else may not work for you.
GLP-1 Medication Level Calculator
Visualize medication levels for your specific GLP-1 medication and plan around peak side effect days.
Try it now →Continue Your GLP-1 Journey
GLP AI Medical Team
Medical & Health Experts
Reviewed by licensed healthcare professionals
Our medical team includes healthcare professionals with expertise in GLP-1 medications, weight management, and nutrition. We provide evidence-based guidance to help you succeed on your GLP-1 journey safely and effectively.